U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
146641146641Study of PRO 140 by Subcutaneous Administration in Adult Subjects With HIV -1 InfectionCompletedHas ResultsHIV -1 Infection|HIV InfectionsDrug: PRO 140 (humanized monoclonal antibody to CCR5)|Drug: Placebo Comparatorhttps://ClinicalTrials.gov/show/NCT00642707
146642146642Time to Remission of Depressive Symptoms With Combined SSRI and RamelteonTerminatedHas ResultsMajor Depressive Disorder|InsomniaDrug: Escitalopram|Drug: Ramelteon|Other: Placebohttps://ClinicalTrials.gov/show/NCT00642694
146643146643Effects of URI on Diabetic Subjects Utilizing Technosphere Insulin After a Meal ChallengeCompletedNo Results AvailableDiabetes Mellitus|Upper Respiratory InfectionDrug: Technosphere Insulinhttps://ClinicalTrials.gov/show/NCT00642681
146644146644A Study of Subcutaneous Mircera for the Maintenance Treatment of Patients With Chronic Renal Anemia Not Receiving ESA Treatment or Dialysis.CompletedNo Results AvailableAnemiaDrug: methoxy polyethylene glycol-epoetin beta [Mircera]https://ClinicalTrials.gov/show/NCT00642668
146645146645Rituximab and Intravenous Immunoglobulin (IVIG) for Desensitization in Renal TransplantationCompletedNo Results AvailableKidney TransplantDrug: IVIG and Rituximabhttps://ClinicalTrials.gov/show/NCT00642655
146646146646Safety and Efficacy Study of Autologous Fibroblasts in the Treatment of Severe Facial Acne ScarringCompletedHas ResultsAcne Scarring of the FaceBiological: Autologous Human Fibroblasts (azficel-T)|Biological: Placebohttps://ClinicalTrials.gov/show/NCT00642642
146647146647A Randomized, Double-blind, Placebo-controlled Clinical Study of the Oral IL-12/23 Inhibitor, STA-5326 Mesylate, Administered to Patients With Rheumatoid Arthritis to Determine Safety, Tolerability, Pharmacokinetic and Synovial Tissue OutcomesCompletedNo Results AvailableActive, Moderate to Severe Rheumatoid ArthritisDrug: STA 5326 mesylate|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00642629
146648146648Evaluate Safety of TI in Diabetic Subjects With Moderate Obstructive Pulmonary Disease (Asthma and COPD)TerminatedNo Results AvailableDiabetic Type 1 With Asthma or COPD|Diabetic Type 2 With Asthma or COPD|Type 1 Diabetes|Type 2 Diabetes|Indeterminate Obstructive Lung DiseaseDrug: Technosphere Insulin|Drug: Usual Carehttps://ClinicalTrials.gov/show/NCT00642616
146649146649A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal CancerTerminatedHas ResultsColorectal CancerDrug: capecitabine [Xeloda]|Drug: capecitabine [Xeloda]|Drug: bevacizumab [Avastin]|Drug: oxaliplatin|Drug: irinotecanhttps://ClinicalTrials.gov/show/NCT00642603
146650146650Lifestyle and Fertility StudyActive, not recruitingNo Results AvailableInfertility|Pregnancy|Fertility|Nutrition|Life Stylehttps://ClinicalTrials.gov/show/NCT00642590
146651146651A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients With Metastatic Colorectal Cancer.CompletedNo Results AvailableColorectal CancerDrug: bevacizumab [Avastin]|Drug: irinotecan|Drug: leucovorin|Drug: fluorouracilhttps://ClinicalTrials.gov/show/NCT00642577
146652146652Study on Migraine and Headache in Epileptic PatientsCompletedNo Results AvailableEpilepsyOther: Observational study in Epileptic Patientshttps://ClinicalTrials.gov/show/NCT00642564
146653146653Beneficial Effects of Long Term Menaquinone-7CompletedNo Results AvailableBone Loss|ArteriosclerosisDietary Supplement: menaquinone-7|Dietary Supplement: placebohttps://ClinicalTrials.gov/show/NCT00642551
146654146654A Study Designed to Determine the Safety and Pharmacological Response ofMKC253 Inhalation Powder in Adults With Type 2 Diabetes MellitusCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: MKC253 Inhalation Powder|Drug: Technosphere Inhalation Powder|Drug: subcutaneous injectionhttps://ClinicalTrials.gov/show/NCT00642538
146655146655Detection of Anastomotic Leakage After Esophageal SurgeryCompletedNo Results AvailableEsophageal Cancer|Anastomotic LeakageProcedure: Contrast swallow radiography, endoscopyhttps://ClinicalTrials.gov/show/NCT00642525
146656146656Dronabinol Versus Standard Ondansetron Antiemetic Therapy in Preventing Delayed-Onset Chemotherapy-Induced Nausea and VomitingCompletedNo Results AvailableChemotherapy Induced Nausea and VomitingDrug: dronabinol|Drug: ondansetron|Drug: dronabinol/ondansetron|Drug: placebohttps://ClinicalTrials.gov/show/NCT00642512
146657146657Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and VomitingCompletedNo Results AvailableHighly Active Antiretroviral Therapy (HAART)-Related Nausea and Vomiting|HIV InfectionsDrug: Dronabinol|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00642499
146658146658Portable Monitoring for Diagnosis and Management of Sleep ApneaCompletedNo Results AvailableSleep Apnea, ObstructiveOther: Portable (Embla Embletta X30 system and Respironic REMStar Auto M series with CFlex)|Other: Standard polysomnography (PSG)https://ClinicalTrials.gov/show/NCT00642486
146659146659MATER Study: A Study of Metronidazole Cream in the Prevention and Treatment of Tarceva (Erlotinib)-Associated RashCompletedNo Results AvailableNon-Squamous Non-Small Cell Lung CancerDrug: erlotinib [Tarceva]|Drug: metronidazole actavis 1% topical creamhttps://ClinicalTrials.gov/show/NCT00642473
146660146660A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA)Active, not recruitingHas ResultsJuvenile Idiopathic ArthritisDrug: tocilizumab [RoActemra/Actemra]|Drug: Placebo|Drug: Non-steroidal anti-inflammatory drugs (NSAIDs)|Drug: methotrexate|Drug: corticosteroidshttps://ClinicalTrials.gov/show/NCT00642460
146661146661Helium:Oxygen Noninvasive Positive Pressure Ventilation in Patients Exposed to Sulfur MustardCompletedNo Results AvailableBronchiolitis|Chronic BronchitisDrug: helium:oxygen mixturehttps://ClinicalTrials.gov/show/NCT00642447
146662146662Comparison of Blood Pressure Medications on MetabolismCompletedNo Results AvailableDiabetesDrug: carvedilol|Drug: metoprololhttps://ClinicalTrials.gov/show/NCT00642434
146663146663Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic PatientsTerminatedNo Results AvailableAcromegalyDrug: C2L-OCT-01 PR, 10 or 20 mg|Drug: C2L-OCT-01 PR, 20 mghttps://ClinicalTrials.gov/show/NCT00642421
146664146664Prevention of Intrauterine Growth Retardation in Hounde District, Burkina FasoCompletedNo Results AvailableMultiple Micronutrient Deficiencies During PregnancyDietary Supplement: Multiple micronutrient supplements (MMN)|Dietary Supplement: IFAhttps://ClinicalTrials.gov/show/NCT00642408
146665146665Velcade®-Melphalan Association in Autologous Stem-Cell Transplantation (ASCT)CompletedNo Results AvailableMultiple MyelomaDrug: Bortezomibhttps://ClinicalTrials.gov/show/NCT00642395
146666146666Safety and Effectiveness of Agilus (Hyaluronic Acid) for Ankle OsteoarthritisTerminatedNo Results AvailableOSTEOARTHRITISDevice: Agilus|Device: Normal salinehttps://ClinicalTrials.gov/show/NCT00642382
146667146667A 4-week, Randomized, Rater-blinded, Parallel Study to Evaluate Quetiapine in Improving Sleep Quality of SchizophreniaCompletedHas ResultsSchizophreniaDrug: quetiapine fumarate|Drug: haloperidolhttps://ClinicalTrials.gov/show/NCT00642369
146668146668Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing OffTerminatedHas ResultsParkinson's DiseaseDrug: Carbidopa/levodopa/entacapone|Drug: Immediate release carbidopa/levodopahttps://ClinicalTrials.gov/show/NCT00642356
146669146669Balance in Children With Cochlear ImplantsCompletedNo Results AvailableSevere, Profound DeafnessBehavioral: Evaluation of motor proficiency skills.|Behavioral: Evaluation of motor proficiency|Behavioral: Evaluation of motor proficiency|Behavioral: Evaluation of motor proficiency.https://ClinicalTrials.gov/show/NCT00642343
146670146670Comparative Study of Efficacy and Safety of Oral Ibuprofen and Intravenous Ibuprofen in Closure of Patent Ductus Arteriosus in Very Low Birth Weight InfantsCompletedNo Results AvailablePatent Ductus ArteriosusDrug: oral ibuprofen|Drug: intravenous ibuprofenhttps://ClinicalTrials.gov/show/NCT00642330

* Görseller ve İçerik tekif hakkına sahip olabilir